Next-Generation Sequencing in Lung Cancers—A Single-Center Experience in Taiwan
<i>Background and Objectives</i>: Lung cancer is a leading cause of cancer mortality in Taiwan. With rapid advancement of targeted therapeutics in non-small cell lung cancers, next-generation sequencing (NGS) is becoming an important tool for biomarker testing. In this study, we describe...
Main Authors: | Wei-An Lai, Yen-Shuo Huang, Kung-Chao Chang, Sheau-Fang Yang, Chih-Jen Yang, Yu-Wei Liu, Huan-Da Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/60/2/236 |
Similar Items
-
Next-generation sequencing of non-small cell lung cancer at a Quebec health care cancer centre
by: Mark Sorin, et al.
Published: (2023-01-01) -
Mutational Profiling of Lung Cancer Using Next Generation Sequencing: A Malaysian Real-World Clinical Diagnostic Experience
by: Pathmanathan Rajadurai, et al.
Published: (2023-01-01) -
Next Generation Sequencing Technology in Lung Cancer Diagnosis
by: Calin Cainap, et al.
Published: (2021-09-01) -
Prevalence of PIK3CA mutations in Taiwanese patients with breast cancer: a retrospective next-generation sequencing database analysis
by: Ta-Chung Chao, et al.
Published: (2023-08-01) -
Diagnosis of lung squamous cell carcinoma based on metagenomic Next-Generation Sequencing
by: Ping Wei, et al.
Published: (2022-03-01)